30970 sets of genes differentially expressed following small molecule perturbations from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
Gene Set |
Description |
BRD-K50387473_XMD-892_MCF7_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A49225603_TRIMEPRAZINE TARTRATE_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45205755_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73368362_BIX-02189_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_HA1E_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_LNCAP_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90382497_GW-843682X_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03449891_foretinib_A549_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31912990_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75931230_7706-0139_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10207760_Lasalocid sodium salt_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32896438_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17140735_-666_VCAP_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A08003242_RHODOMYRTOXIN B_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73293050_S1170_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81814927_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A41519720_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05804044_AZ-628_HT29_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A36275421_MW-ras12_RMUGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18497530_EI-293_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A87137733_GSK-690693_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35638681_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02680176_Clofilium tosylate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02637541_celecoxib_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16977723_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19540840_saracatinib_HCC515_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A31575449_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43002773_GDC-0068_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84203638_4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]-N-(4-methylpyridin-2-yl)butanamide_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93918653_quizartinib_MCF7_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57011718_UK 356618_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61033289_15-Deoxy-?12,14-prostaglandin J2_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79554012_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28360340_TW 37_RMUGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78867378_mw-A1-12_DV90_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A04756508_NORGESTIMATE_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A43126523_NCGC00183690-01_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98143437_SB-239063_PC3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13807286_S1071_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75919782_Folinic acid calcium salt_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A38425832_NCGC00229596-01_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09951645_dabrafenib_A375_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05434375_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45498368_HY-10044_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25662647_FU_JMBII105B_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28428262_S1084_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86284654_Alfacalcidol_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07023879_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K55070890_thiothixene_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25004090_erastin_A375_24.0_h_4.8_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69516039_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_HT29_24.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_SKBR3_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58247702_NCGC00183913-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06476055_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14109347_LY2603618_MCF7_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74305673_IMD 0354_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_HS578T_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A59985574_T542500_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42419294_7287-0921_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A66559694_NALTREXONE HYDROCHLORIDE_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A10523515_GSK-429286A_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52321331_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50000283_PHA-767491_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07667918_linsitinib_MCF10A_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39093044_K784-3187_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37456065_VU0365114-2_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89059493_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77286328_R3904_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A22684332_Procaterol hydrochloride_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60219430_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95435023_PHA-665752_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94294671_A-1065_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85985071_E3380_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K11540476_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A36630025_-666_RMGI_6.0_h_0.35_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_-666_HA1E_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32501161_GBR 12909 dihydrochloride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25775766_Securinine_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66884694_NCGC00167398-02_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67090983_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_HY-11001_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29395450_PIK-93_MCF7_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99545815_HY-10459_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U70626184_BI-2536_PC3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21520694_Sulfacetamide sodic hydrate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_HME1_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97274161_N-{2-[benzyl(isopropyl)amino]ethyl}-4-({[(4-methylphenyl)sulfonyl]amino}methyl)benzamide_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72864428_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_A375_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78716413_Compound 10_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92317137_-666_THP1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33551950_R2146_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54233340_Dorsomorphin dihydrochloride_HCT116_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05151076_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02950022_BMS 299897_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46056750_AZD-7762_HCC515_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25737009_-666_T3M10_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17743697_KB-R7943 mesylate_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64157027_ZD 2079 hydrochloride_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74710236_VU0410183-2_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24132293_PIPLARTINE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23931216_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_U937_6.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54256913_MK-1775_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K30351863_NCGC00185090-03_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A50928468_NORGESTREL_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16533489_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42499654_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26674531_GR-235_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20285085_R406_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A51777634_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87990216_Piretanide_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A00420644_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92571446_WZ-3105_MCF7_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64366758_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05804044_AZ-628_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76907295_VU0418947-2_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57282030_JW-7-24-1_BT20_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34533029_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77830450_forskolin_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_LNCAP_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_MCF7_24.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94173926_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_PC3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56957086_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63606607_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66254772_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25979535_8009-6730_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A26711594_NICARDIPINE HYDROCHLORIDE_EFO27_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79404599_HY-10342_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A47816767_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42693031_Glimepiride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67090983_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI 2536_SW620_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19894101_MST- 312_A549_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48488978_YM-201636_SKBR3_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31706415_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39646320_H7270_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92241597_CHR 2797_HCT116_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U33728988_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69328504_L-690,488_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90382497_GW-843682X_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25650355_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66782112_ICI-162,846_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16541732_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34581968_BMS-536924_SKMEL28_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61717269_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A47513740_calyculin A_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61401890_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77547509_3-cyclohexyl-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyrimidine-2,4(1H,3H)-dione_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80431395_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24102129_-666_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08547377_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82685933_BTB06091SC_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83213911_PF 750_SKMEL28_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62459624_T5212475_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99749624_linifanib_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A85860691_chaetocin_LOVO_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09602097_Forskolin_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05331696_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_A549_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44978960_NCGC00010428-03_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06712146_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49094915_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78122587_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32610195_BL-095_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68065987_MK-2206_EFO27_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A82096673_KUC103428N_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78126613_MENADIONE_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06956503_NCGC00187945-01_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68065211_2-[(chloroacetyl)(3-chlorophenyl)amino]-N-cyclohexyl-2-pyridin-3-ylacetamide_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_S1036_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15010982_10006350_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49630153_NCGC00183226-01_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18518344_Digitoxigenin_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26664453_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51575138_TPCA-1_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07212038_SELINIDIN_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14221570_Benzopurpurin (B)_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19633847_PERHEXILINE MALEATE_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80700417_SGI-1776_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17705806_JTC 801_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31342827_GF 109203X_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_HY-10192_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10484463_1483-0018_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71799949_carbamazepine_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79239947_PF 573228_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_BT20_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61323504_SB 225002_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66032149_VU0365117-1_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20000640_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A56592690_PX12_A375_6.0_h_30.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_MCF10A_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69852452_7241-4207_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18909381_CGS 12066B_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59317601_INK-128_PC3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12762134_-666_MCF7_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48488978_YM-201636_MDAMB231_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21672174_Ro 28-1675 ?_MCF7_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14618467_IKK 16_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68174511_torin-2_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39256324_Rottlerin_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13566078_BMS-345541_HME1_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87932577_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59317601_INK-128_MCF7_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_MDAMB231_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39503511_MK-0591_SW948_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67868012_PI 103 hydrochloride_MCF7_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A62025033_temsirolimus [CI779]_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25736793_everolimus_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69688083_mestinon_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06569345_HG-5-88-01_HME1_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_ZSTK-474_BT20_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21672174_Ro 28-1675 ?_DV90_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_VCAP_24.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15475572_MLS-0390837.0001_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06792661_Narciclasine_SKMEL1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U00779237_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A41250306_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U61997977_WZ-4-145_SKBR3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48803730_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-M64432851_S1042_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52989797_Clomipramine hydrochloride_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85275009_methyl 4-hydroxy-2-(trifluoromethyl)thieno[3,4-b]pyridine-7-carboxylate MAY_9_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84450674_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05104363_PD-184352_HT29_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28307902_Flutamide_MCF7_24.0_h_28.96_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12502280_TG101348_THP1_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A56592690_PX12_VCAP_6.0_h_30.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10705233_GW405833 hydrochloride_SKMEL1_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61033289_15-Deoxy-?12,14-prostaglandin J2_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07259155_NCGC00182362-01_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03736784_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32405725_E933505_MCF7_24.0_h_88.8_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28366633_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79092138_NITROFURAZONE_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63913457_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83213911_PF 750_HT29_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20755323_-666_CORL23_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A82307304_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49945136_GR 113808_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05104363_HY-50295_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87142802_veliparib_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75144621_digoxin_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_A549_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06180729_DM163 BRD-K06180729_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20755323_-666_MCF7_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-M16762496_S1205_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_MCF7_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78062244_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68336408_Tyrphostin AG 1478_A549_6.0_h_56.78_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20755323_-666_HCC515_24.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23478508_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51751936_Alfadolone acetate_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K11795542_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56343971_vemurafenib_MCF10A_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A24021119_NCGC00183696-01_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93443135_6-(3,5-dimethylisoxazol-4-yl)quinazolin-4(3H)-one 0033-034_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92317137_-666_NCIH1836_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78930611_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_MCF7_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K30677119_PP-30_SKLU1_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_HY-50877_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72636697_QL-X-138_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14888893_minoxidil_SW620_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26669427_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54606188_(+)-JQ1_A375_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46056750_AZD-7762_MCF10A_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80431395_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16621777_S1174_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_SKBR3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74402642_Chemistry 2804_RKO_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31342827_GF-109203X_NCIH2073_6.0_h_12.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74514084_S1035_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35920785_2-(4-(2-chlorophenylamino)-6-(pyrrolidin-1-yl)-1,3,5-triazin-2-ylamino)ethanol wh-gc-round5-01_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02708799_GSK-1059615_HME1_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U43867373_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64642496_-666_VCAP_24.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00007652_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24496482_SB590885_MDAMB231_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62459624_T5212475_NEU_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54256913_MK-1775_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A93942655_NCGC00188535-01_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59369769_tozasertib_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98203492_GSK-J4_HA1E_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_BT20_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10916986_S1527_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25144184_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47983010_BX-795_RMUGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05549170_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87158025_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92571446_WZ-3105_MCF7_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K38756014_G-201_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_HA1E_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A98283014_C3930_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62965247_Tipifarnib-P2_THP1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31699485_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45205755_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_BT20_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56653679_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U32365159_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K55187425_ON-01910_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47869605_podofilox_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_-666_RKO_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32610195_BL-095_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_HY-50877_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41895714_AS-605240_MCF7_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81209159_HERNIARIN_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87510569_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78659596_MLN2238_HEC108_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33583600_ISOLIQUIRITIGENIN_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52075040_-666_NCIH508_6.0_h_44.4_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63923597_S1147_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32944375_NCGC00184834-01_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56343971_PLX-4032_PL21_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92571446_WZ-3105_HS578T_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09549677_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74761218_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76694128_DCC-2036_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_HME1_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43782924_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00910650_NCGC00242335-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19724398_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49371609_528116.cdx_NCIH596_6.0_h_0.09_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17896185_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U51024685_HG-6-64-01_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A79768653_sirolimus_PC3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19295594_-666_U937_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09951645_dabrafenib_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81528515_nilotinib_A549_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_BT20_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08219523_5-nonyloxytryptamine_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04412738_tramadol_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25736793_everolimus_HCC515_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10065684_DANTHRON_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_NVP-BEZ235_HA1E_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56411643_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15108141_gemcitabine_A549_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01578344_-666_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89224880_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75301702_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94544211_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03642198_AY 9944_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A73909368_DACTINOMYCIN_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59273480_PROPENTOFYLLINE_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A90643929_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A11706664_EI-332_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54997624_BYL719_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_NVP-BEZ235_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26241953_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_LNCAP_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49328571_dasatinib_A549_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U33728988_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19796430_LDE225 (NVP-LDE225)_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53959060_Indirubin-3-oxime_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_BT20_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67075780_TGX-115_HT29_24.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81418486_vorinostat_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34495954_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18917088_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A48237631_MITOMYCIN C_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A26595446_T0513-6584_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_A375_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99749624_linifanib_HME1_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_BT20_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A81530502_8009-7630_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19724398_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K30707190_PNU 74654_PC3_24.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33720404_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_MCF10A_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58767537_afatinib_LNCAP_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92317137_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A85860691_chaetocin_A375_24.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_HY-50767_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20285085_fostamatinib_HME1_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01121114_AT-MLPCN CSC-006_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_LNCAP_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18419789_Etoposide_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42828737_sutent_HCC515_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49049886_CGS 15943_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15791587_L-733,060 hydrochloride_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93080877_Ala-Ala-Phe-CMK_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93747373_HG-5-113-01_HS578T_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34092011_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A35108200_Dexamethasone_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45399554_CAM-9-027-3_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A50675702_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04548931_EPIRUBICIN HYDROCHLORIDE_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K11696279_BU 239 hydrochloride_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_NCIH596_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51575138_TPCA-1_HCC515_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90382497_GW-843682X_HT29_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_BT20_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63550407_Erythromycin_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19687926_HY-50898_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60476892_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71799778_BML-259_SW948_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79425933_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A97437073_Rosiglitazone_PC3_24.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A31107743_89671_EFO27_6.0_h_0.09_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81169441_cerivastatin na_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35430135_SR 59230A hydrochloride_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61829047_7b-cis_MDST8_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29905972_S1005_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65814004_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52075040_-666_AGS_6.0_h_44.4_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25775766_Securinine_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98251413_IOX2_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A50675702_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12502280_TG-101348_MDAMB231_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26818574_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33272502_DG-041_SW480_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A46747628_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84709232_Caffeic acid phenethyl ester_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80431395_TRICIRIBINE_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41731458_TRICLOSAN_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69852452_7241-4207_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26664453_-666_A673_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A50774520_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI 2536_SKLU1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66909449_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78599730_manumycin A_MCF7_24.0_h_9.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28120222_Prestw-550_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_MDAMB231_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A43087975_5540735_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15079084_phorbol-12-myristate-13-acetate (PMA)_HCT116_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08878345_MLS-0075347.0001_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77908580_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67537649_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88378636_withaferin-a_HME1_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66763349_STOCK1S-03920_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A79768653_sirolimus_H1299_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65182930_NVP-AUY922_HS578T_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_NVP-TAE684_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68174511_torin-2_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64785675_S1352_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73261812_-666_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64634304_Retinoic acid_VCAP_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29395450_PIK-93_HS578T_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58767537_afatinib_HME1_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09854848_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94176593_TWS-119_BT20_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78838262_AUSTRICINE_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49183052_VU0415113-1_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39268308_epibatidine (+/-)_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A47816767_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_A549_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94176593_TWS-119_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12906962_DICHLOROBENZAMIL_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20755323_-666_SW948_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A60245366_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89224880_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82036761_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59317601_INK-128_HCC515_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96704648_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71103788_DULOXETINE HYDROCHLORIDE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_HEPG2_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44276885_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33312228_halometasone_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_WSUDLCL2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48803730_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09499853_KU 0060648 trihydrochloride_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56429665_Calcipotriol_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70549064_EI-156_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51377689_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02708799_GSK-1059615_LNCAP_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01493881_A3145_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34415467_Trimethobenzamide hydrochloride_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08307026_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A30655177_LFM-A13_HCC515_24.0_h_111.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_MCF7_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48654774_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K91701654_70970_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97764662_PD-173074_HS578T_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21672423_7611062_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09499853_KU 0060648 trihydrochloride_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81142122_STK249718_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60298136_ITE_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09499853_KU 0060648 trihydrochloride_LOVO_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A94756469_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A24021119_NCGC00183696-01_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81418486_vorinostat_SNUC4_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17497770_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_HA1E_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78431006_HY-50878_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03015355_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26104851_Nifuroxazide_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28907958_-666_TYKNU_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60866521_idelalisib_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K27305650_LY-294002_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06980535_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74931283_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43068349_AMG 9810_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68739437_NPK76-II-72-1_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_-666_SKM1_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28307902_Flutamide_VCAP_24.0_h_28.96_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60219430_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52512893_SC 19220_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15108141_gemcitabine_HCC515_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04430056_-666_MCF7_24.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A81795050_U 18666A_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_BT20_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_MCF7_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65182930_NVP-AUY922_HCC515_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18763547_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75302809_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08799216_pelitinib_A549_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77908580_entinostat_HA1E_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_PC3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47635719_Dexamethasone acetate_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32485462_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A16998493_etodolac_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17497770_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82731415_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U64521890_XMD16-144_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03816923_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_HY-10192_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_NVP-BEZ235_BT20_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82823804_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40902647_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_ZSTK-474_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21672174_Ro 28-1675 ?_SW620_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A52650764_Ingenol 3, 20-dibenzoate_SKLU1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12539581_Nocodazole_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82823804_PD 407824_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82216340_medroxyprogesterone 17-acetate_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A10523515_GSK-429286A_A549_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86899078_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A76941896_Doxorubicin hydrochloride_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K27665173_PDGF Receptor Tyrosine Kinase Inhibitor I_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65955264_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66254772_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36354764_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A34817987_itraconazole_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36363294_I-BET151_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57304726_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73418978_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U61997977_WZ-4-145_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16485616_mocetinostat_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A35869383_ibrutinib_HCC515_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A56020723_CA-074-Me_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62012036_GR-108_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U60236422_WH-4-025_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79511609_2-chloroadenosine_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_SNGM_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41185612_NCGC00187483-01_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08619838_Tremorine dihydrochloride_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98519396_NP-010155_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A41451487_PK-11195_HT29_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96704648_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A11087911_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56653679_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04534322_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45399554_CAM-9-027-3_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68929948_DAPT_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53414658_tivozanib_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71303366_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18761689_4-(5-(3-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid WFM1.17B_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35128472_CC-100_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74305673_IMD 0354_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00954209_7643453_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14609189_3-(5-{[3-(4-methoxy-2-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene}-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)propanoic acid_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19918940_LOMATIN_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18726304_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02822062_CT-200783_HEC108_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74133369_495455_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32821942_Azathioprine;446-86-6_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54906270_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16189898_CHIR-99021_HS578T_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35708212_Strophantine octahydrate_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_palbociclib_HME1_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53417444_OTSSP167_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41337261_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A11007541_B4313_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09537769_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77547509_3-cyclohexyl-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyrimidine-2,4(1H,3H)-dione_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26838195_AST1306_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93623501_NCGC00186101-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_ZSTK-474_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79390395_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04853698_-666_H1299_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A93236127_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40956802_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U08759356_EI-346_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A44008656_DOXYLAMINE SUCCINATE_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U60236422_WH-4-025_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66198023_losartan_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45498368_WYE-125132_MDAMB231_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A11706664_EI-332_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20742498_RS 39604 hydrochloride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28366633_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A72180425_2-[(chloroacetyl)(4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thien-2-ylacetamide_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78549347_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68407802_KIN001-055_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78056905_MLS-0390851.0001_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A80151636_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74305673_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32010074_mw-A1-14 BRD-K32010074_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93296644_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89005359_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_JNK-9L_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51791390_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_MCF10A_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00824317_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_NVP-TAE684_HME1_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89209981_(4-(hydroxydiphenylmethyl)-1H-1,2,3-triazol-1-yl)(4-(hydroxydiphenylmethyl)piperidin-1-yl)methanone_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68143200_-666_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88172511_naltrexone_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99616396_S1032_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A80502530_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19918940_LOMATIN_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09951645_dabrafenib_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HME1_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90826279_-666_HA1E_24.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58767537_afatinib_SKBR3_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U44618005_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19633847_PERHEXILINE MALEATE_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49669041_BX-912_MCF10A_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45746021_CC-401_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31238592_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A96799240_GR-109_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95785537_PP 2_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93788137_PF-431396_HS578T_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64642496_-666_HCC515_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24132293_piperlongumine (HPLC)_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78062244_STOCK1N-27488_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_LOVO_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58698715_4-Methoxy-2-(4-propoxy-phenyl)-quinazoline BRD-K58698715_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56343971_PLX-4032_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87947369_VX-680_MDST8_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39746403_ERYTHROMYCIN ESTOLATE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37865504_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68739437_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_MCF10A_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82928847_rocilinostat_MCF7_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08316444_-666_PC3_24.0_h_0.63_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23673040_(Naphthalen-1-ylamino)-acetic acid [1-(5-nitro-furan-2-yl)-meth-(E)-ylidene]-hydrazide_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05402890_NCGC00165289-01_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A05565054_(2-ethylpiperidin-1-yl)(4-(hydroxydiphenylmethyl)-1H-1,2,3-triazol-1-yl)methanone_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86472598_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A81541225_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81473043_-666_RMUGS_6.0_h_0.35_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84937637_A-275_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58306044_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_HME1_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14109347_LY2603618_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69688083_mestinon_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75999307_NCGC00182357-01_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67506692_EI-263_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31238592_Devazepide_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A41451487_PK-11195_VCAP_24.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81418486_vorinostat_CORL23_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16485616_mocetinostat_A375_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A21584801_brivanib_MCF10A_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A35588707_TENIPOSIDE_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99545815_PF-562271_MDAMB231_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_-666_SKMEL28_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_MDAMB231_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83289131_CAY10618_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33086940_JAS07_007_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15079084_phorbol-12-myristate-13-acetate (PMA)_TYKNU_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81592585_DM-55-3 BRD-K81592585_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19166598_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A62326914_paroxetine_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08619574_Thioproperazine dimesylate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19687926_lapatinib_SKBR3_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86930074_S1017_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97330509_Src Kinase Inhibitor II_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04853698_-666_SNUC4_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_HCC515_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06792661_Narciclasine_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65182930_NVP-AUY922_BT20_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92301463_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_HY-10005_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34776109_Glimepiride_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15563106_-666_MCF7_24.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54997624_BYL719_SKBR3_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85606544_neratinib_HCC515_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42489623_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15108141_gemcitabine_NCIH2073_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53972329_ruxolitinib_SKBR3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57282030_JW-7-24-1_MDAMB231_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54256913_MK-1775_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42452249_EO 1428_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97764662_3044_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06593056_-666_HA1E_24.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67566344_KU-0063794_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A56592690_PX12_SW620_6.0_h_30.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_MCF10A_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42489623_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A06929388_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87990216_Piretanide_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A37704979_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_SKBR3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50311478_Na-Tosyl-Phe Chloromethyl Ketone_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72029282_Probucol_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_HCC515_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97764662_341607_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_-666_NOMO1_6.0_h_0.63_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_LNCAP_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A72180425_K784-3188_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29506255_NCGC00185087-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31688005_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44100512_KIN001-043_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15415227_GW 1929_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58564983_SELAMECTIN_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65182930_NVP-AUY922_PC3_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_MCF10A_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14920963_ERYTHROSINE SODIUM_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24132293_piperlongumine (HPLC)_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96809896_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59369769_HY-10161_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08799216_pelitinib_BT20_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_HT29_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A54927599_KF 38789_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86301799_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A67788537_Salermide_SNGM_6.0_h_120.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52163391_NCGC00165208-01_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_THP1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15297126_FLUOCINONIDE_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A62326914_paroxetine_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68548958_-666_A375_6.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15563106_-666_HCC515_24.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25088322_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13087974_D3943_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19540840_saracatinib_BT20_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_MCF10A_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89853519_FISETINIDOL_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40255344_EI-215_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13049116_BMS-754807_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A67799922_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83189926_UNC1215_PC3_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42021584_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87947369_VX-680_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A77216878_manumycin A_T3M10_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74148702_curcumin_AGS_6.0_h_48.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09186807_KIN001-244_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31342827_GF-109203X_SW620_6.0_h_12.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_MDAMB231_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A04172077_NP-002491_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53792571_Inhibitor BEC hydrochloride_RMUGS_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20285085_fostamatinib_HME1_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03981224_Ethisterone_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24156250_NCGC00182393-01_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73109821_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58767537_afatinib_BT20_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_LNCAP_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10484463_1483-0018_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99545815_PF-562271_MDAMB231_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A76528577_Vincristine sulfate_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13650332_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72414522_AZD-5438_LNCAP_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56334280_S1367_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65786282_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36198571_WAY 170523_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74133369_495455_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25737009_-666_SNGM_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44100512_KIN001-043_HME1_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_HME1_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61776140_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A89337244_PD 102807_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19037878_trichostatin A_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31856043_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_SKLU1_6.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15567136_PAPAVERINE HYDROCHLORIDE_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16485616_mocetinostat_HCC515_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI 2536_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75641298_METOCLOPRAMIDE HYDROCHLORIDE_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76703230_YM-155_NCIH596_6.0_h_0.31_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K27316855_calcitriol_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94018295_STOCK2S-79598_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16730910_regorafenib_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76205745_Losartan Potassium_U937_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89692698_-666_A375_24.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12787259_CX-5461_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12539581_Nocodazole_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00234327_RU 24969_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23165181_NCGC00241357-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94176593_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80672993_Compound 58_SW620_6.0_h_88.8_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20285085_fostamatinib_MCF7_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_HA1E_24.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10870738_CDC_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50387473_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_BT20_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A77824596_FLUOCINOLONE ACETONIDE_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70161581_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31313613_BS-181_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81651477_Parthenolide_RMUGS_6.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_HA1E_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A47829399_artesunate_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65417056_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88378636_withaferin-a_MCF10A_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40255344_EI-215_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54997624_BYL719_MCF10A_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_MCF10A_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03618428_PP-110_MCF7_6.0_h_22.2_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A77299732_Salubrinal_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41895714_AS-605240_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-M16762496_S1205_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37312348_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04853698_LDN-193189_A549_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77987382_Mebendazole_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15916496_Clotrimazole_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93480852_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08502430_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15600710_S1057_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71879491_tretinoin_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12120659_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_MCF7_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84203638_4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]-N-(4-methylpyridin-2-yl)butanamide_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68548958_-666_HEPG2_6.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23192422_L-6307_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35960502_NICLOSAMIDE_SKM1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_MDAMB231_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K27169919_ethyl {[4-(4-fluorophenyl)-6-(trifluoromethyl)-2-pyrimidinyl]sulfonyl}acetate_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40645748_mefloquine_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63630713_ethacrynic acid_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_A549_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_NCIH596_6.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50866992_tropisetron hcl_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75999307_NCGC00182357-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A81530502_8009-7630_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53414658_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19037878_trichostatin A_A673_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44432556_VU0418946-2_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U94846492_Quinine hemisulfate salt monohydrate_MDST8_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45033733_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U88459701_atorvastatin_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08316444_-666_VCAP_6.0_h_0.63_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12787259_CX-5461_A549_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20526256_HG-14-10-04_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85606544_neratinib_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28120222_Prestw-550_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05653692_DL-PDMP_A549_24.0_h_64.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A20243730_Danazol_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88832793_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36363294_I-BET151_A375_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04695623_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54018158_MLS-0216981_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_SKBR3_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A80775386_GR-237_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A55756846_EI-148_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A24021119_NCGC00183696-01_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15108141_gemcitabine_VCAP_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_HS578T_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09602097_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77547509_3-cyclohexyl-6-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}pyrimidine-2,4(1H,3H)-dione_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56515112_Medrysone_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10010115_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77286328_R3904_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20755323_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47983010_BX-795_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93658967_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45498368_WYE-125132_HS578T_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05510762_Granisetron_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93034159_2-chloro-2-deoxyadenosine_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66707493_LAWSONE_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_palbociclib_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66296774_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72414522_AZD-5438_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61718261_NCGC00182361-01_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_MCF10A_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71459254_CYMARIN_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39093044_K784-3187_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49061529_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A17065207_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_HT29_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02708799_GSK-1059615_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16189898_CHIR-99021_MDAMB231_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92428232_GSK-461364_HCC515_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A64228451_EI-328_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71879491_tretinoin_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78637815_LY 320135_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90027355_spironolactone_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U25771771_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_MCF10A_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12516989_Zaprinast_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82732294_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63195589_Tipifarnib-P1_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73789395_ZM 336372_SKLU1_6.0_h_102.71_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A32161980_H-5832_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10705233_GW405833 hydrochloride_SW620_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87904882_chelerythrine chloride_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28907958_-666_SKLU1_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65814004_Diphenyleneiodonium chloride_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47659338_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_HME1_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95435023_PHA-665752_A375_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A60245366_AS-601245_MCF7_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14888893_minoxidil_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A23801136_Rifabutin_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24859147_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_BT20_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67075780_TGX-115_MDST8_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36533576_KUC103875 KUC103875N_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06765193_(E)-2-(1H-Benzoimidazol-2-yl)-3-(5-nitro-furan-2-yl)-acrylonitrile BRD-K06765193_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28180706_4-chloro-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzamide_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51575138_TPCA-1_SNGM_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67100011_Pivmecillinam hydrochloride_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44100512_KIN001-043_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02590140_O-2050_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16485616_S1122_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_PC3_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54233340_Dorsomorphin dihydrochloride_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A63894585_Clobetasol propionate_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26760349_HG-9-91-01_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64881305_S1452_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70578146_dactinomycin_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20742498_RS 39604 hydrochloride_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62459624_T5212475_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A64290322_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03618428_PP-110_THP1_6.0_h_22.2_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15419449_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_HCC515_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95858622_NCGC00182609-01_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18725729_2-[(chloroacetyl)(4-chlorophenyl)amino]-N-cyclohexyl-2-(4-methoxyphenyl)acetamide_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_HS578T_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13914662_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31342827_GF-109203X_THP1_6.0_h_12.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80786583_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13094524_PFI-1_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52075040_-666_HEC108_6.0_h_44.4_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U94846492_Quinine hemisulfate salt monohydrate_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46056750_AZD-7762_HCC515_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56411643_-666_HEC108_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03857568_1-Methyl-3-nitro-4-p-tolylsulfanyl-1H-quinolin-2-one BRD-K03857568_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73155123_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45044657_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_BT20_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31412180_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56751279_Y-39983_MDAMB231_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88625236_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45435259_r(+)-sch-23390_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A55369275_CGP 54626 hydrochloride_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45333398_PERIPLOCYMARIN_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80094086_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78659596_MLN2238_SKMEL1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49371609_528116.cdx_NCIH2073_6.0_h_0.09_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79353516_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09778810_FGIN-1-27_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90446118_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88677950_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07859598_Raf1 Kinase Inhibitor I_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08547377_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92571446_WZ-3105_HS578T_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49075727_nintedanib_LNCAP_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A03323675_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76205745_Losartan Potassium_RMGI_6.0_h_160.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45498368_WYE-125132_HT29_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68009927_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45205755_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_-666_AGS_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95435023_PHA-665752_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A93393712_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88707333_NCGC00182378-01_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00816165_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88707333_NCGC00182378-01_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10705233_GW405833 hydrochloride_HCC515_6.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A85587465_MDL 72222_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A96485169_EBPC_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A02481876_Importazole_SKLU1_6.0_h_60.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A02481876_Importazole_HEPG2_6.0_h_60.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04695623_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88378636_withaferin-a_MCF10A_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85606544_neratinib_HS578T_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68588778_6942543_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K55116708_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45399554_CAM-9-027-3_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67847053_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83794624_P8624_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A36630025_-666_HT29_6.0_h_0.35_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58853583_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A61470182_N-FORMYLMETHIONYLALANINE_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67537649_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83972459_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08109215_I-BET_A549_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23984367_S1040_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_NVP-BEZ235_SKBR3_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41924482_7674034_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_MDAMB231_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09635314_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K30677119_PP-30_MCF7_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39188321_Betamethasone_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68548958_-666_MDST8_6.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09416995_LOVASTATIN_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74148702_curcumin_SW620_6.0_h_48.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87909389_alvocidib_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61105081_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68065987_MK-2206_MDAMB231_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68065987_MK-2206_HS578T_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63945320_DIHYDROSAMIDIN_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A00267231_HEMADO_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_LNCAP_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60932973_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24132293_PIPLARTINE_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A42649439_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31342827_GF-109203X_WSUDLCL2_6.0_h_12.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96799727_-666_MDST8_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HME1_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66876909_linezolid_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-M86331534_BJM-ctd2-9_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99749624_linifanib_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A40431293_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_BT20_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82577285_DIPROPYLDOPAMINE_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64052750_gefitinib_SKBR3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73368362_BIX-02189_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73945663_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63072637_Pyrantel tartrate_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U07805514_saracatinib_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35424586_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54606188_(+)-JQ1_A549_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U60236422_WH-4-025_BT20_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17075857_Chloroxine_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K22096725_ALW-II-49-7_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76907295_VU0418947-2_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18194590_MEPHENTERMINE SULFATE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67868012_PI-103_SKBR3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A95820578_NP-006304_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74486276_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39944607_32937_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92241597_CHR 2797_HEC108_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97534490_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63569039_NCGC00012508-02_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83963101_MLN-8054_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_MDAMB231_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95785537_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44432556_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68548958_-666_HT29_24.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HME1_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99252563_QL-XII-47_MCF10A_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64857848_XMD-885_HCC515_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36363294_I-BET151_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46419649_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A58280226_Y27632_VCAP_6.0_h_4.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_JNK-9L_BT20_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A61825514_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08845546_FK506_VCAP_6.0_h_22.2_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U60236422_WH-4-025_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_MCF10A_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49328571_dasatinib_HT29_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14200658_Syrosingopine_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A06276885_N-Benzylnaltrindole hydrochloride_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57169635_dacomitinib_A549_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68336408_Tyrphostin AG 1478_MCF7_6.0_h_56.78_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16189898_CHIR-99021_HA1E_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A23689620_Avermectin B1a_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36363294_I-BET151_HT29_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15834839_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61829047_7b-cis_NCIH1836_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25736793_everolimus_A549_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U51024685_HG-6-64-01_SKBR3_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63828191_Raloxifene hydrochloride_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A10977446_CARVEDILOL_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K30523950_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71823332_S1297_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K25731886_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A65767837_HYDROCORTISONE ACETATE_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33379087_tivantinib_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09951645_dabrafenib_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02113016_AZD2281 (KU59436)_HT29_6.0_h_44.4_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25088322_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13646352_PKC-412_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07691486_roscovitine_BT20_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69406317_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U64521890_XMD16-144_MCF7_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70771662_11K-629S_NEU_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68174511_torin-2_MCF10A_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72414522_AZD-5438_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48970916_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_BT20_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80672993_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08589866_OSI-906_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20986251_BL-076_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03449891_foretinib_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50204028_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77908580_entinostat_MCF7_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HCC515_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57282030_JW-7-24-1_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05804044_AZ-628_HT29_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99633092_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A05352148_Ipratropium bromide_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13662825_dinaciclib_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13133631_FLUOROMETHOLONE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64052750_gefitinib_LNCAP_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A85860691_chaetocin_DV90_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A47513740_calyculin A_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08478539_RLM-2-12_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93123848_RAF 265_A375_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04949373_Parthenolide_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI 2536_WSUDLCL2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A59145032_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10705233_GW405833 hydrochloride_HT29_24.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_HCC15_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92241597_CHR 2797_WSUDLCL2_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K77947974_Fluspirilen_HT29_6.0_h_4.21_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37687095_AZD-8330_HS578T_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96799727_Pifithrin- ?_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21680192_mitoxantrone_LNCAP_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21672423_7611062_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74305673_IMD 0354_SNUC4_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389675_DAUNORUBICIN_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33551950_R2146_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14109347_LY2603618_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74710236_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96799727_-666_A673_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56343971_HY-10247_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39484304_triptolide_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78599730_manumycin A_VCAP_6.0_h_9.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12787259_CX-5461_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43620258_3,5-dichloro-2-hydroxy-N-(2-methoxy-5-phenylphenyl)benzenesulfonamide_SW480_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_NOMO1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51608872_N,N-dimethyl-6-({[1-(1-naphthyl)-1H-tetrazol-5-yl]thio}methyl)-1,3,5-triazine-2,4-diamine_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76703230_YM-155_LOVO_6.0_h_0.31_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76694128_DCC-2036_HCC515_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78431006_HY-50878_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A98378129_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A52530684_DOXORUBICIN_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A31800922_Procyclidine hydrochloride_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66874953_Pifithrin-a_HEPG2_6.0_h_69.83_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A84445767_NCGC00238548-02_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76908866_HY-11008_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68174511_torin-2_SKBR3_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31841256_5353451_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A62025033_temsirolimus [CI779]_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_WSUDLCL2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74949371_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K04887706_AKT-inhibitor-1-2_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_H1299_6.0_h_177.600006104_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47869605_podofilox_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_MDST8_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13169950_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31238592_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21680192_mitoxantrone_MDAMB231_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68739437_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A76528577_Vincristine sulfate_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39522003_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U37049823_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15025317_Bay 11-7821_SW948_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71266197_-666_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96354014_Nifedipine_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99252563_QL-XII-47_HME1_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90382497_GW-843682X_SKBR3_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85606544_HKI-272_OV7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80786583_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50387473_XMD-892_HCC515_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93461745_buspar_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14329163_(S)-(-)-Bay K 8644_U937_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02708799_GSK-1059615_HT29_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57037351_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A68061604_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98548675_Parthenolide_LOVO_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72726508_Arcyriaflavin A_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82091397_HY-11068_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71554540_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86797399_pracinostat_HCC515_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82566177_PSH_026_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21680192_mitoxantrone_HME1_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18724229_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59184148_SB 216763_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97764662_341607_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53903639_480743.cdx_PC3_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99252563_QL-XII-47_BT20_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64634304_Retinoic acid_A375_24.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10906552_7887507_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K38634661_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07762753_Aminopurvalanol A_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A61599461_NCGC00229600-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_HME1_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07005393_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68202742_trichostatin A_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A81772229_Simvastatin_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28105619_curcubitacin I_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95901403_S1118_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12184916_NVP-BEZ235_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03449891_foretinib_HEPG2_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76840893_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A44827100_eryped_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A76019558_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19724398_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37392901_NSC 632839 hydrochloride_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16195444_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53878242_MMPX_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16290432_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45540146_KI20227_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66037923_NCGC00182390-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37194137_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A60386802_MLS-0315872.0001_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42308740_ST056792_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59058766_CHLORPROTHIXENE HYDROCHLORIDE_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45735142_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12502280_TG101348_SNUC4_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19227686_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_SKBR3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68336408_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29673530_HYPERICIN_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08619574_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50168500_canertinib_HME1_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_HY-10192_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_MDAMB231_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00337317_NU-7441_MDAMB231_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K48654774_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A06352508_SB 218078_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97764662_341607_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_HCC515_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_S1072_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79779816_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88789588_Letrozole_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40624912_ZM 39923 hydrochloride_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17674993_Diflorasone Diacetate_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A26595446_T0513-6584_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K15716662_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_SKBR3_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41731458_TRICLOSAN_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A48237631_MITOMYCIN C_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68174511_torin-2_MCF10A_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A59985574_T542500_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A29901043_HY-11066_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28366633_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71707563_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K03063480_PF-477736_SKBR3_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70251741_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31856043_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45333398_PERIPLOCYMARIN_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A36630025_-666_TYKNU_6.0_h_0.35_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28907958_-666_RMUGS_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_HT29_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K91370081_Anisomycin_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86761848_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54997624_BYL719_BT20_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68191783_ALW-II-38-3_HA1E_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62289640_Lylamine hydrochloride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69840642_HDAC6 inhibitor ISOX_DV90_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_SKBR3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99252563_QL-XII-47_BT20_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63675182_TRIFLUPROMAZINE HYDROCHLORIDE_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37720887_SB-525334_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36737713_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41895714_AS-605240_HT29_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_HME1_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99545815_PF-562271_SKBR3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50140147_NVP-TAE684_MCF10A_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84770158_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45086103_Sulfaguanidine_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A36630025_-666_AGS_6.0_h_0.35_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23673040_(Naphthalen-1-ylamino)-acetic acid [1-(5-nitro-furan-2-yl)-meth-(E)-ylidene]-hydrazide_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44849676_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56343971_PLX-4032_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88551539_10012682_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39520573_GW 5074_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28907958_-666_NCIH596_6.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A22707317_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23192422_L-6307_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A55913614_Primaquine diphosphate_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62810658_PD 98059_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18725729_2-[(chloroacetyl)(4-chlorophenyl)amino]-N-cyclohexyl-2-(4-methoxyphenyl)acetamide_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A49848186_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82135108_elesclomol_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K97516968_VU0418000-1_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49055432_A66_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K24496482_SB590885_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A06390036_HYDROQUINIDINE_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75409952_wortmannin_CORL23_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37392901_NSC 632839 hydrochloride_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51918615_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06426971_Ryuvidine_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02965346_SU-11274_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K34968258_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28746609_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10361096_NCGC00165199-01_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20000640_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A85860691_chaetocin_OV7_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78867378_mw-A1-12_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K47635719_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_BT20_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A52650764_Ingenol 3, 20-dibenzoate_RKO_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99252563_QL-XII-47_MDAMB231_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73261812_-666_SKMEL28_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_SKBR3_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K14221570_Benzopurpurin (B)_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_MCF10A_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K67090983_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78126613_MENADIONE_SKLU1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21680192_mitoxantrone_HT29_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43736954_Cortisone_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A52650764_Ingenol 3, 20-dibenzoate_AGS_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A03623303_METOPROLOL TARTRATE_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K20742498_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86492010_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99615199_medroxyprogesterone_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_A549_24.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K38251852_Paxilline_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A93975555_NCGC00167107-01_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59369769_tozasertib_BT20_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49371609_528116.cdx_MCF7_6.0_h_0.09_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44100512_KIN001-043_A375_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_MCF10A_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K11153516_iniparib_HEPG2_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39944607_32937_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64857848_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K44241590_847943_HA1E_24.0_h_11.1_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K22385716_LY 303511_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_BT20_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_LNCAP_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A99571536_Dubinidine_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06980535_PROMAZINE HYDROCHLORIDE_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A29901043_KIN001-127_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43620258_3,5-dichloro-2-hydroxy-N-(2-methoxy-5-phenylphenyl)benzenesulfonamide_CORL23_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A79465854_auranofin_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19540840_saracatinib_MDAMB231_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52163391_NCGC00165208-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A45498368_WYE-125132_HCC515_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49328571_dasatinib_HME1_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U33728988_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K93788137_PF-431396_HS578T_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K16478699_PLX-4720_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83670234_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_CL34_6.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K41895714_AS-605240_HME1_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52836380_AZD-7545-A_HEPG2_6.0_h_22.2_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_palbociclib_BT20_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12343256_trametinib_A549_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A55946879_BW-B 70C_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K39345836_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72636697_QL-X-138_HEPG2_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84663978_Trequinsin hydrochloride_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K84595254_Strophanthidin_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01806521_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U41416256_THZ-2-98-01_HT29_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71303366_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68407802_KIN001-055_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68548958_-666_MCF7_6.0_h_20.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49657628_AG 18_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73261812_-666_PL21_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A54880345_etomidate_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_PC3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K59222562_NCGC00185984-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI 2536_CORL23_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_LNCAP_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A12409803_-666_A375_24.0_h_40.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21064560_PALDA_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01436366_XMD-1150_HS578T_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76908866_CP-724714_SKBR3_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75999307_NCGC00182357-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HT29_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32828673_Chelidonine (+)_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18726304_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49010888_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13122391_16-HYDROXYTRIPTOLIDE_NCIH596_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92241597_CHR 2797_LOVO_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K53308430_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A06664848_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05520923_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09951645_dabrafenib_A375_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10705233_GW 405833_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10906552_7887507_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88573743_A443654_HME1_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K91623615_ABT-751_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71382703_methyl 5-{2-[(4-chloroanilino)carbothioyl]carbohydrazonoyl}-1-(2,4-difluorophenyl)-1H-pyrazole-4-carboxylate MLS-0437443.0001_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HT29_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_JNK-9L_MDAMB231_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18419789_Etoposide_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51730347_diphenylcyclopropenone_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A35623999_CGP 37157_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A10523515_GSK-429286A_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62459624_T5212475_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02526760_QS 11_SKM1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68191783_ALW-II-38-3_HEPG2_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62310379_Fluticasone propionate_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21680192_mitoxantrone_SKBR3_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19037878_trichostatin A_HCC15_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64890080_BI-2536_PC3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_ZSTK-474_HS578T_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39522003_OMDM-2_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06426971_Ryuvidine_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_NOMO1_6.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74148702_curcumin_MCF7_6.0_h_48.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78513633_Lonidamine_A549_6.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72192970_ST019365_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K99545815_PF-562271_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37764012_PF-3758309_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46056750_AZD-7762_MDAMB231_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02708799_GSK-1059615_PC3_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K35960502_NICLOSAMIDE_THP1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49294207_BIBU 1361 dihydrochloride_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64755930_Etazolate hydrochloride_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K98714523_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K60866521_idelalisib_A375_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92571446_WZ-3105_SKBR3_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69097969_VU0418939-2_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79404599_HY-10342_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K91900765_S1458_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52075715_-666_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A97437073_Rosiglitazone_HA1E_24.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K56957086_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86269644_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A41692738_TGX-221_MCF10A_3_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26104851_Nifuroxazide_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95435023_PHA-665752_MDAMB231_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06854232_AM580_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81876028_CP 93129 dihydrochloride_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51443908_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_palbociclib_LNCAP_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A82913781_MLS-0425590.0001_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07859598_Raf1 Kinase Inhibitor I_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07995125_KUC104487 KUC104487N_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69600043_Thiethylperazine dimalate_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39996500_radicicol_MCF10A_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78431006_crizotinib_HS578T_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K10042277_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K23673040_(Naphthalen-1-ylamino)-acetic acid [1-(5-nitro-furan-2-yl)-meth-(E)-ylidene]-hydrazide_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A10715913_SULPIRIDE_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36354764_-666_HCC515_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K87947369_VX-680_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_MCF10A_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69516039_MLS-0435541.0001_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K11634954_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A31312900_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K45399554_CAM-9-027 BRD-K45399554_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A70449690_forskolin_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_selumetinib_A549_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28360340_TW 37_SKMEL28_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K82731415_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69852452_7241-4207_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09549677_Mibefradil dihydrochloride_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28610502_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K09790412_EI-195_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50168500_canertinib_SKBR3_3_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K55454768_TAS 301_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_LNCAP_3_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K55630727_T5840683_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49865102_PD-0325901_BT20_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42191735_buparlisib_SKBR3_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K86930074_S1017_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_A375_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K83972459_JWE-035_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89014967_S1475_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U29336476_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52522949_-666_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K96799727_-666_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95808480_taxifolin-(+/-)_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43068349_AMG 9810_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92241597_CHR 2797_H1299_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K02562327_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K69181860_arg-csc-91_SKLU1_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79090631_CGP-60474_PC3_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K26756394_VE821_A549_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A13122391_16-HYDROXYTRIPTOLIDE_HCC515_24.0_h_0.08_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19687926_lapatinib_BT20_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76933066_NCGC00183218-01_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K46056750_AZD-7762_MCF7_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K29506255_NCGC00185087-01_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A83855350_Naltrexone hydrochloride_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K66254772_-666_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K63068307_ZSTK-474_HA1E_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85015012_NNC 05-2090 hydrochloride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A92826379_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K28296557_Akt inhibitor IV_HT115_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71726959_N9-ISOPROPYL-OLOMOUCINE_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A34299591_Budesonide_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58479490_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K75958195_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_HT29_6.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K19220233_JNK-9L_LNCAP_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K76401790_JNK-IN-5A_HCC515_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08799216_pelitinib_MCF10A_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74305673_IMD 0354_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94012289_OSI-027_HME1_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_MCF7_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K07303502_Arachidonyl trifluoro-methyl ketone_MDST8_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64857848_XMD-885_HCC515_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57238941_NCGC00167097-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K21064560_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K61718261_NCGC00182361-01_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K81528515_nilotinib_HS578T_3_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54256913_MK-1775_MCF7_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06405410_-666_A549_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K33483813_actarit_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95037415_NCGC00167094-01_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A52530684_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K85606544_neratinib_MDAMB231_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K79222491_2-morpholino-9-(thiophen-3-yl)-N-((5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methyl)-9H-purin-6-amine_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K70161581_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A18328003_GDC-0980_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57080016_selumetinib_BT20_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00486786_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A28746609_PACLITAXEL_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A72711497_LASALOCID SODIUM_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15530910_SDZ 21009_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43389698_BMS-387032_MCF7_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K13390322_AT-7519_LNCAP_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K32944375_NCGC00184834-01_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19037878_trichostatin A_SNGM_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25736793_everolimus_HCC515_24_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K65404805_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K62459624_T5212475_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K00824317_Flurandrenolide_HCC515_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K68143200_-666_PL21_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A77216878_manumycin A_RMGI_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_OV7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A39646320_H7270_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92991072_PAC 1_NCIH2073_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K74430258_-666_HEPG2_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71322910_ST012525_PC3_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95435023_PHA-665752_HEPG2_24_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49712247_NCGC00167098-01_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K05104363_PD-184352_MDAMB231_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K95309561_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K58479490_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12994359_Valdecoxib_PC3_6.0_h_177.6_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K51313569_palbociclib_HS578T_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U41416256_THZ-2-98-01_BT20_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K12040459_AT7867_PC3_24_h_10_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K06009608_-666_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89997465_-666_MCF7_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75769826_SDM25N hydrochloride_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K50841342_PAC 1_A375_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A92439610_TRIAMCINOLONE ACETONIDE_A549_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-U61997977_WZ-4-145_A375_24_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K92991072_PAC 1_CL34_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K89748981_MLS-0454415.0001_VCAP_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K27440500_NCGC00183243-01_HT29_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K57930080_4-(3,4-dimethoxyphenyl)pyridine hydrobromide WG-7_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K64800655_PHA-793887_HEPG2_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A75478957_PD 166793_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17210248_S1216_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K73293050_S1170_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A15914070_-666_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K42918627_GSK-2126458_SKBR3_3_h_3.33_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K36363294_I-BET151_HA1E_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K43620258_3,5-dichloro-2-hydroxy-N-(2-methoxy-5-phenylphenyl)benzenesulfonamide_THP1_6.0_h_80.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K18163752_-666_SKB_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17743125_belinostat_PC3_24_h_1.11_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K17110974_-666_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K90430314_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A69815203_CYCLOSPORINE_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A25687296_-666_PHH_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K01976263_Emetine Dihydrochloride Hydrate (74)_JHUEM2_6.0_h_0.63_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K37991163_PAROXETINE HYDROCHLORIDE_HA1E_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K31633810_-666_NPC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K40175214_torin-1_MDAMB231_3_h_0.12_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A19500257_geldanamycin_NCIH2073_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94325918_-666_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K52911425_GDC-0941_MCF7_24_h_0.37_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A22713669_BVT 948_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K78659596_MLN2238_SKMEL28_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88510285_B675700.cdx_WSUDLCL2_6.0_h_0.04_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-A43126523_NCGC00183690-01_VCAP_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K49371609_528116.cdx_A375_6.0_h_0.09_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K80786583_-666_MCF7_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K71059170_Cefixime_HA1E_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K88707333_NCGC00182378-01_HT29_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K08417745_SID 26681509_HT29_24.0_h_88.8_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K72451865_-666_ASC_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K94176593_TWS119_PC3_24.0_h_10.0_um
|
small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit]
|
BRD-K54070802_MLS-0315803_A375_6.0_h_10.0_um
|
small molecule perturbation identified as [perturbation I |